Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

BACKGROUND: Epidemiologic and laboratory investigations suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) have chemopreventive effects against breast cancer due to their activity against cyclooxygenase-2 (COX-2), the rate-limiting enzyme of the prostaglandin cascade. METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Randall E, Beebe-Donk, Joanne, Alshafie, Galal A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373658/
https://www.ncbi.nlm.nih.gov/pubmed/16445867
http://dx.doi.org/10.1186/1471-2407-6-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373658/
https://www.ncbi.nlm.nih.gov/pubmed/16445867
http://dx.doi.org/10.1186/1471-2407-6-27

Ejemplares similares